With world-class expertise in ctDNA analysis, Inivata is committed to partnering with pharmaceutical and biotech companies to accelerate clinical research to aid development of targeted therapies and immuno-oncology drugs and improve patient outcomes.

Inivata can provide comprehensive ctDNA testing services to our pharma/biotech partners for:

–  Molecular stratification
–  Monitoring treatment response
–  Detection of disease relapse
–  Identification of resistance mutations
–  Detection of minimal residual disease
–  Earlier diagnosis

To find out more about our products,  find out which events and conferences we are attending and contact us for further information on partnering opportunities.